The investments of Michael Honsue Cho

Michael Honsue Cho invests and operates across biotechnology, artificial intelligence, hospitality, consumer brands, resources and gaming, through entities based in Australia, Hong Kong and the United States. He has committed tens of millions of dollars of his own capital to the photodynamic therapy programme over two decades, subscribed for $5.5 million of shares in ASX-listed Invion Limited and underwrote a $2.5 million rights issue, and led the seven-figure round that took Ink Nurse into North America. His ventures range from a clinical-stage cancer therapeutics programme and a crypto gaming platform carrying more than 2,500 titles, through to two Melbourne dining venues and a high-grade gold project in north-east Victoria.